Immunohistochemistry-Based Fluorescent Nanoparticle Assay for Determination of Antibody Binding Capacity and Its Correlation with Flow Cytometry Analysis

被引:0
作者
Tatsumi, Atsuro [1 ,3 ]
Morichika, Keisuke [1 ]
Krueger, Joseph [2 ]
Yokota, Hiroyuki [1 ]
机构
[1] KONICA MINOLTA INC, Precis Med Business Unit, Healthcare Business Headquarters, Tokyo, Japan
[2] Invicro, Adv Pathol Serv, Needham, MA USA
[3] KONICA MINOLTA INC, Precis Med Business Unit, Healthcare Business Headquarters, 1 Sakuramachi, Hino, Tokyo 1918511, Japan
关键词
Antibody binding capacity; immunohistochemistry; flow cytometry; fluorescent nanoparticle; RECEPTOR OCCUPANCY;
D O I
10.1080/00032719.2022.2153365
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The determination of antibody binding capacity is crucial in the development of drug antibodies. Despite its widespread use, flow cytometry may only be used to evaluate single cells in solution. In addition, analyzing the antibody localization in tissue sections of animal models after drug administration, as in immunohistochemistry (IHC), is desirable. In this study, antibody-treated cells were fixed on glass slides, and their analysis was directly compared with flow cytometry. Cell-bound antibodies were quantitatively detected using a method that relies on phosphor-integrated dots (PIDs), which are highly brilliant nanoparticles applicable to immunohistochemistry. The outcomes of this approach were highly correlated with flow cytometry, suggesting that it is able to quantitatively detect cell-bound antibodies at a level comparable with flow cytometry. Therefore, this novel IHC-based technique is valuable for quantitative analysis and localization of antibodies in tissue sections of drug administration.
引用
收藏
页码:2053 / 2060
页数:8
相关论文
共 16 条
  • [1] Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness
    Gonda, Kohsuke
    Watanabe, Mika
    Tada, Hiroshi
    Miyashita, Minoru
    Takahashi-Aoyama, Yayoi
    Kamei, Takashi
    Ishida, Takanori
    Usami, Shin
    Hirakawa, Hisashi
    Kakugawa, Yoichiro
    Hamanaka, Yohei
    Yoshida, Ryuichi
    Furuta, Akihiko
    Okada, Hisatake
    Goda, Hideki
    Negishi, Hiroshi
    Takanashi, Kensaku
    Takahashi, Masaru
    Ozaki, Yuichi
    Yoshihara, Yuka
    Nakano, Yasushi
    Ohuchi, Noriaki
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [2] Automated Quantification of Extranuclear ER Using Phosphor-Integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2- Breast Cancer
    Guo, Zhaorong
    Tada, Hiroshi
    Kitamura, Narufumi
    Hamada, Yoh
    Miyashita, Minoru
    Harada-Shoji, Narumi
    Sato, Akiko
    Hamanaka, Yohei
    Tsuboi, Kouki
    Harada, Nobuhisa
    Takano-Kasuya, Mayumi
    Okada, Hisatake
    Nakano, Yasushi
    Ohuchi, Noriaki
    Hayashi, Shin-ichi
    Ishida, Takanori
    Gonda, Kohsuke
    [J]. CANCERS, 2019, 11 (04):
  • [3] A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study
    Hicks, David G.
    Buscaglia, Brandon
    Goda, Hideki
    McMahon, Loralee
    Natori, Takako
    Turner, Bradley
    Soukiazian, Armen
    Okada, Hisatake
    Nakano, Yasushi
    [J]. BMC CANCER, 2018, 18
  • [4] Bispecific antibodies
    Kontermann, Roland E.
    Brinkmann, Ulrich
    [J]. DRUG DISCOVERY TODAY, 2015, 20 (07) : 838 - 847
  • [5] Kranz DM., 2016, F1000Res, V5, pF1000 Faculty R, DOI [10.12688/f1000research.9073.1, DOI 10.12688/F1000RESEARCH.9073.1]
  • [6] Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development
    Liang, Meina
    Schwickart, Martin
    Schneider, Amy K.
    Vainshtein, Inna
    Del Nagro, Christopher
    Standifer, Nathan
    Roskos, Lorin K.
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (02) : 117 - 127
  • [7] Magaki S, 2019, METHODS MOL BIOL, V1897, P289, DOI 10.1007/978-1-4939-8935-5_25
  • [8] Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers
    O'Hurley, Gillian
    Sjosted, Evelina
    Rahman, Arman
    Li, Bo
    Kampf, Caroline
    Ponten, Fredrik
    Gallagher, William M.
    Lindskog, Cecilia
    [J]. MOLECULAR ONCOLOGY, 2014, 8 (04): : 783 - 798
  • [9] Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody
    Staflin, Karin
    de Zafra, Christina L. Zuch
    Schutt, Leah K.
    Clark, Vanessa
    Zhong, Fiona
    Hristopoulos, Maria
    Clark, Robyn
    Li, Ji
    Mathieu, Mary
    Chen, Xiaocheng
    Johnston, Jennifer
    Low, Justin
    Ybarra, Ryan
    Slaga, Dionysos
    Yang, Jihong
    Ovacik, Meric
    Dybdal, Noel O.
    Totpal, Klara
    Junttila, Melissa R.
    Ellerman, Diego
    Lee, Genee
    Dennis, Mark S.
    Prell, Rodney
    Junttila, Teemu T.
    [J]. JCI INSIGHT, 2020, 5 (07)
  • [10] A weighted method for estimation of receptor occupancy for pharmacodynamic measurements in drug development
    Sternebring, Ola
    Alifrangis, Lene
    Christensen, Toke Folke
    Ji, Hong
    Hegelund, Anne Charlotte
    Hogerkorp, Carl-Magnus
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (02) : 220 - 229